Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Darius

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Pharmacology|May 26, 1995
Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMPA Fisch, J Michael-Hepp, J Meyer, et al.
Zeitschrift Fur Kardiologie|November 1, 1996
[Effect of intracoronary and intravenous iloprost on coronary blood flow velocity in patients with coronary heart disease]M Buerke, H Darius, H J Rupprecht, et al.
European Journal of Medical Research|March 19, 1996
Clinical assessment of periodontal conditions in patients treated with nifedipineC Neumann, B Willershausen-Zönnchen, C Klug, et al.
Agents and Actions. Supplements|January 1, 1992
Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprostM Buerke, H A Dieterich, J Meyer, et al.
Der Internist|October 1, 1992
[Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases]H Darius, R Erbel, G G Belz, et al.
European Journal of Pharmacology|June 7, 1985
Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivativesE F Smith, H Darius, H Ferber, et al.
Circulation|August 5, 1997
Prostacyclin receptor desensitization is a reversible phenomenon in human plateletsA Fisch, K Tobusch, K Veit, et al.
Zeitschrift Fur Kardiologie|July 20, 2000
[A case report: suppurative pericardial effusion]K Zacharowski, S Kessler, F Bittinger, et al.
European Journal of Pharmacology|June 13, 1994
Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182H Darius, J Michael-Hepp, K H Thierauch, et al.
Thrombosis Research|February 9, 1999
Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery diseaseS Lindemann, B Klingel, A Fisch, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Pharmacology|May 26, 1995
Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMPA Fisch, J Michael-Hepp, J Meyer, et al.
Zeitschrift Fur Kardiologie|November 1, 1996
[Effect of intracoronary and intravenous iloprost on coronary blood flow velocity in patients with coronary heart disease]M Buerke, H Darius, H J Rupprecht, et al.
European Journal of Medical Research|March 19, 1996
Clinical assessment of periodontal conditions in patients treated with nifedipineC Neumann, B Willershausen-Zönnchen, C Klug, et al.
Agents and Actions. Supplements|January 1, 1992
Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprostM Buerke, H A Dieterich, J Meyer, et al.
Der Internist|October 1, 1992
[Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases]H Darius, R Erbel, G G Belz, et al.
European Journal of Pharmacology|June 7, 1985
Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivativesE F Smith, H Darius, H Ferber, et al.
Circulation|August 5, 1997
Prostacyclin receptor desensitization is a reversible phenomenon in human plateletsA Fisch, K Tobusch, K Veit, et al.
Zeitschrift Fur Kardiologie|July 20, 2000
[A case report: suppurative pericardial effusion]K Zacharowski, S Kessler, F Bittinger, et al.
European Journal of Pharmacology|June 13, 1994
Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182H Darius, J Michael-Hepp, K H Thierauch, et al.
Thrombosis Research|February 9, 1999
Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery diseaseS Lindemann, B Klingel, A Fisch, et al.
Pageof 14